Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 21,841 results that match your search.21,841 results
  • In connection with the promotion or advertising of their goods, companies often try to compare their product offerings with those of a competitor. The use of comparative advertising often raises the question of how to refer to a third party brand properly without infringing that party's proprietary rights. This issue also arises when a company offers a service that directly relates to an already existing third party product offering and that company wants to reference the third-party brand in order to describe the services it offers (and the relative advantages).
  • Brazil: Brazil opened the .com.br domain – previously restricted to local companies – to Brazilian citizens and residents last month. According to law firm Ladas & Parry, the development may call for more defensive registrations, as it poses an increased risk of cybersquatting by Brazilian individuals.
  • Your company learns that a competitor has copied the invention in one of your most valuable patents. Your patent counsel advises there is a strong case of infringement, and your company initiates a suit. During discovery it is revealed that a second person contributed to the invention, but was not identified as an inventor in the patent.
  • The first Geneva Convention was signed in 1864 to protect the sick and wounded in times of war. Since then, there have been numerous additions and revisions to this statute. The Geneva Conventions comprise four treaties devised in Geneva, Switzerland, that set the benchmark for international law relating to humanitarian concerns. Singapore acceded to the four Geneva Conventions of 1949 on April 27 1973. As at August 2 2006, these conventions have been ratified by 194 countries.
  • The law on disclosing clinical trial data looks set to change following a recent announcement by the UK government. The rationale behind the proposed changes, which are due to be introduced into UK law by the end of this year, is that pharmaceutical companies should be in no doubt as to their responsibility to disclose any information they have that would have a bearing on the protection of health.
  • In Ahmed Oomerbhoy & Anr v Gautam Tank & Ors 2008 (36) PTC 193 (Del) an order was filed against plaintiff no 1, a partnership firm, who had taken over the possession of the partnership business assets of a company which was trading as M/s Ahmed Mills; stipulating that they safeguard all trade marks and take action against any unauthorized usage. The first plaintiff had been carrying on the business of manufacture, distribution, sale and dealing in edible oils for more than 50 years under its various trade marks including Postman, registered under the Trade and Merchandise Act, 1958. The firm also has a copyright for the artistic labels under the Copyright Act, 1957. The trade mark registrations are still valid while the design registered with effect from March 29 1989 expired in 2004. Also, the mark and device of Postman have acquired substantial reputation and goodwill in the market on account of use of its mark continuously and extensively up to 2000.
  • The adoption and use of a trade mark can be time consuming and expensive and can present unseen risks. Advertising activity and its regulations often interfere with trade mark use and registration. Some of the most relevant restrictions apply to tobacco products, alcoholic beverages, games of chance and children advertising on TV and radio.
  • The Lower Chamber of the Chilean Congress recently ratified the Agreement on the Requirements for Wine Labelling, agreed on January 23 2007, in Canberra, Australia, in the framework of the World Wine Trade Group (WWTG), the informal grouping of industry representatives from wine-producing countries. The countries that participate in the WWTG are Argentina, Australia, Canada, New Zealand, the US and Chile. These countries represent 25% of the wine world trade.
  • Israel has increasingly become an important centre for conducting multinational clinical trials, with major pharmaceutical companies sponsoring trials in the country's many academic and medical facilities. With high-quality medical professionals and leading academics, in addition to a diverse population base and a modernized regulatory environment, Israel is an attractive venue for conducting clinical research.
  • The Czech courts have recently had the opportunity to apply the famous case of BMW v Deenik C-63/97, with a somewhat unusual result.